Revance Therapeutics Inc (NASDAQ: RVNC): Do Not Miss The Gain Train
Revance Therapeutics Inc (RVNC) concluded trading on Thursday at a closing price of $3.63, with 8.17 million shares of worth about $29.66 million changed hands on the day. Half year performance of the stock remained negative as price took a plunge of -1.89% during that period and on January 30, 2025 the price saw a […]
